Background
- Recent data demonstrates promising effects on left ventricular (LV) dysfunction and LV ejection fraction (EF) improvement following ablation for atrial fibrillation (AF) in patients with heart failure (HF). We sought to study the relationship between LVEF, NYHA class on presentation and the endpoints of mortality and HF admissions in the CASTLE-AF study population. Furthermore, predictors for LVEF improvement were examined.
Methods
- The CASTLE-AF patients with coexisting HF and AF (n=363) were randomized in a multicenter prospective controlled fashion to ablation (n=179) vs pharmacological therapy (n=184). LV function and NYHA class were assessed at baseline (after randomization) and at each follow-up visit.
Results
- In the ablation arm, a significantly higher number of patients experienced an improvement in their LVEF to >35% at the end of the study (OR=2.17; p<0.001). Compared to the pharmacological therapy arm, both ablation patient groups with severe (<20%) or moderate/severe (≥20% and <35%)) baseline LVEF had a significantly lower number of composite endpoints (hazard ratio (HR) =0.60; p=0.006), all-cause mortality (HR=0.54; p=0.019) and cardiovascular (CV) hospitalizations (HR=0.66; p=0.017). In the ablation group, NYHA I/II patients at the time of treatment had the strongest improvement in clinical outcomes (primary endpoint: HR=0.43; p<0.001; mortality: HR=0.30; p=0.001).
Conclusions
- Compared to pharmacological treatment, AF ablation was associated with a significant improvement in LVEF, independent from the severity of LV dysfunction. AF ablation should be performed at early stages of the patient's HF symptoms.
Introduction: CAD (coronary artery disease) is a leading cause of death and disability in developed nations. Exercise testing is recommended as a first-line diagnostic test for patients with stable angina pectoris. In addition to myocardial strain, high-sensitivity CRP (hs-CRP) can predict the presence of significant coronary artery disease. Aim of work: The purpose of this study was to demonstrate the utility of 2D-speckle tracking at rest and under stress along with hs-CRP for detection of CAD in patients who were referred to the chest pain unit with stable or low risk unstable angina pectoris. Methods: A total of 108 individuals met the inclusion criteria and gave their written consent to participate in this study. Coronary angiography was performed within 48 h after admission to the chest pain unit. Myocardial strain was recorded at rest and during dobutamine administration. Results: Global longitudinal strain at stress appeared to be moderately correlated with the presence of significant coronary artery disease (CAD); r = 0.41, p < 0.0001. A moderate correlation was also found between global longitudinal strain at stress and the severity of coronary occlusion; r = 0.62, p < 0.0001. With a cut-off value of −19.1, global longitudinal strain under stress had a sensitivity of 74.1% and a specificity of 76.7% for detecting significant CAD. Hs-CRP was significantly higher in patients with manifested CAD. Conclusion: Evaluation of longitudinal strain parameters at rest and under stress may predict coronary artery disease in patients with stable angina pectoris. A measurable Hs-CRP is a potential marker of coronary stenosis. Strain data could assist in diagnosing CAD severity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.